Literature DB >> 6797532

Diabetes, intrauterine devices, and fibrinolysis.

G M Craig.   

Abstract

Entities:  

Mesh：

Year:  1981        PMID： 6797532      PMCID： PMC1507379          DOI： 10.1136/bmj.283.6301.1264-b

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN： 0267-0623


× No keyword cloud information.
  4 in total

1.  Fibrinolytic activity of the endometrium in diabetic women using Cu-IUDs.

Authors:  B Larsson; K Karlsson; P Liedholm; T Rådberg; A Skryten; B Astedt
Journal:  Contraception       Date:  1977-06       Impact factor: 3.375

2.  Vascular prostacyclin may be reduced in diabetes in man.

Authors:  M Johnson; H E Harrison; A T Raftery; J B Elder
Journal:  Lancet       Date:  1979-02-10       Impact factor: 79.321

3.  Plasminogen activators in the endometrium. II. Clinical aspects. Variation in the concentration of plasminogen activators during the menstrual cycle and its relation to menstrual blood loss.

Authors:  G Rybo
Journal:  Acta Obstet Gynecol Scand       Date:  1966       Impact factor: 3.636

Review 4.  Contraception for the insulin-dependent diabetic woman: the view from one clinic.

Authors:  J M Steel; L J Duncan
Journal:  Diabetes Care       Date:  1980 Jul-Aug       Impact factor: 19.112
  4 in total
  1 in total

Review 1.  The Intrauterine Device in Women with Diabetes Mellitus Type I and II: A Systematic Review.

Authors:  Norman D Goldstuck; Petrus S Steyn
Journal:  ISRN Obstet Gynecol       Date:  2013-12-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.